Appendix 4E and Financial Report
Filed with ASX · · 63 pages · English
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Recce Confirms Delivery by Intravenous Drip
- Recce achieves milestone with volume production
- Recce constructs automated manufacturing facility to support
- Recce secures up to A$6.05 million investment agreement with
- Recce moves closer to clinical study application
Later from Recce Pharmaceuticals
- Recce Confirms Pre-IND Data Submission to US FDA
- Response to ASX Price Query
- Recce Launches Share Purchase Plan
- Appendix 4C - quarterly
- US FDA Grants Qualified Infectious Disease Product Designati
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals